Aprea Therapeutics, Inc. (APRE)
R&D Expenses
$6.72M
TTM · Period ending: · USD
APRE R&D Expenses
Latest reported$6.72Mperiod ending
Latest reported$6.72Mperiod ending
APRE R&D Expenses ($13.39M → $6.72M)
Annual R&D Expenses
High-resolution chart · PNG
APRE r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 7,043,035 | |
| 9,363,537 | |
| 7,627,491 | |
| 92,422,457 | |
| 23,895,875 | |
| 37,879,325 | |
| 20,950,672 | |
| 14,194,732 | |
| 13,392,631 |